<code id='CBA6BBD854'></code><style id='CBA6BBD854'></style>
    • <acronym id='CBA6BBD854'></acronym>
      <center id='CBA6BBD854'><center id='CBA6BBD854'><tfoot id='CBA6BBD854'></tfoot></center><abbr id='CBA6BBD854'><dir id='CBA6BBD854'><tfoot id='CBA6BBD854'></tfoot><noframes id='CBA6BBD854'>

    • <optgroup id='CBA6BBD854'><strike id='CBA6BBD854'><sup id='CBA6BBD854'></sup></strike><code id='CBA6BBD854'></code></optgroup>
        1. <b id='CBA6BBD854'><label id='CBA6BBD854'><select id='CBA6BBD854'><dt id='CBA6BBD854'><span id='CBA6BBD854'></span></dt></select></label></b><u id='CBA6BBD854'></u>
          <i id='CBA6BBD854'><strike id='CBA6BBD854'><tt id='CBA6BBD854'><pre id='CBA6BBD854'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:315
          A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

          Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

          Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron. 

          advertisement

          “It has been exciting to be involved,” Gorham wrote. 

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Neurocrine congenital adrenal hyperplasia trial succeeds
          Neurocrine congenital adrenal hyperplasia trial succeeds

          AdobeSANDIEGO—NeurocrineBiosciencesannouncedonTuesdaythatanexperimentaldrugforcongenitaladrenalhyper

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          The struggle to figure out which patients 'deserve' Wegovy

          AdobeThereisjustnotenoughWegovy.Thecurrentmanufacturingshortagewilleventuallyend,andthosewhohaveheal